Dmitry Balyasny’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-100,680
| Closed | -$16.6M | – | 2673 |
|
|
2021
Q2 | $16.6M | Sell |
100,680
-128,821
| -56% | -$21.5M | 0.08% | 342 |
|
|
2021
Q1 | $35.2M | Buy |
229,501
+225,340
| +5,416% | +$30.6M | 0.17% | 139 |
|
|
2020
Q4 | $522K | Sell |
4,161
-3,749
| -47% | -$419K | ﹤0.01% | 1124 |
|
|
2020
Q3 | $802K | Sell |
7,910
-29,497
| -79% | -$3.01M | 0.01% | 1040 |
|
|
2020
Q2 | $3.64M | Buy |
37,407
+23,204
| +163% | +$2.16M | 0.03% | 598 |
|
|
2020
Q1 | $1.18M | Buy |
+14,203
| New | +$1.39M | 0.01% | 724 |
|
|
2019
Q3 | – | Sell |
-24,270
| Closed | -$2.41M | – | 1746 |
|
|
2019
Q2 | $2.41M | Sell |
24,270
-13,613
| -36% | -$1.3M | 0.02% | 821 |
|
|
2019
Q1 | $4.18M | Buy |
37,883
+30,825
| +437% | +$3.22M | 0.03% | 611 |
|
|
2018
Q4 | $649K | Sell |
7,058
-42,350
| -86% | -$4.29M | ﹤0.01% | 1030 |
|
|
2018
Q3 | $5.44M | Sell |
49,408
-41,797
| -46% | -$4.35M | 0.02% | 671 |
|
|
2018
Q2 | $8.52M | Sell |
91,205
-10,951
| -11% | -$943K | 0.04% | 529 |
|
|
2018
Q1 | $8.47M | Sell |
102,156
-148,800
| -59% | -$13.2M | 0.04% | 571 |
|
|
2017
Q4 | $22.9M | Buy |
250,956
+35,712
| +17% | +$2.97M | 0.07% | 362 |
|
|
2017
Q3 | $16.4M | Buy |
215,244
+57,831
| +37% | +$4.37M | 0.06% | 366 |
|
|
2017
Q2 | $11.8M | Buy |
157,413
+26,713
| +20% | +$1.85M | 0.05% | 491 |
|
|
2017
Q1 | $8.53M | Sell |
130,700
-76,712
| -37% | -$4.52M | 0.04% | 550 |
|
|
2016
Q4 | $11.4M | Buy |
207,412
+23,580
| +13% | +$1.29M | 0.06% | 442 |
|
|
2016
Q3 | $10.4M | Buy |
+183,832
| New | +$9.01M | 0.06% | 379 |
|
Other funds holding PRAH
Dmitry Balyasny's PRAH Position: Q3 2021 in Review
Dmitry Balyasny sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 100,680 shares — an estimated $16.6M sold.
Dmitry Balyasny first reported a position in PRAH in Q3 2016 and held it in 18 quarters. The position peaked at $35.2M in Q1 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- Dmitry Balyasny reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Dmitry Balyasny sold 100,680 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $16.6M.
- Dmitry Balyasny first reported a position in PRA Health Sciences, Inc. in Q3 2016 and held it in 18 quarters.
- Dmitry Balyasny's PRA Health Sciences, Inc. position peaked at $35.2M in Q1 2021.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on Balyasny Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.